Patents by Inventor Divyang Patel

Divyang Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240374528
    Abstract: Provided herein are modified release multiparticulate dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. The dosage forms are easily administered to a subject on a once-daily or twice daily basis, and provide a safe and effective pharmacokinetic profile.
    Type: Application
    Filed: September 16, 2022
    Publication date: November 14, 2024
    Inventors: Mayank JOSHI, Sandeep PANDITA, Divyang PATEL, Soumen PATTANAYEK, Parag SHAH
  • Publication number: 20240307313
    Abstract: Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile for the active agent indicating treatment efficacy over an extended period of time.
    Type: Application
    Filed: March 19, 2024
    Publication date: September 19, 2024
    Inventors: Parag Shah, Mayank Joshi, Soumen Pattanayek, Divyang Patel, Sandeep Pandita
  • Publication number: 20230390192
    Abstract: Provided herein are controlled release gastro retentive dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile.
    Type: Application
    Filed: October 12, 2021
    Publication date: December 7, 2023
    Inventors: Mayank JOSHI, Parag SHAH, Soumen PATTANAYEK, Divyang PATEL, Sandeep PANDITA
  • Publication number: 20230364075
    Abstract: Provided herein are controlled release multiparticulate dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile.
    Type: Application
    Filed: September 17, 2021
    Publication date: November 16, 2023
    Inventors: Mayank JOSHI, Parag SHAH, Soumen PATTANAYEK, Divyang PATEL, Sandeep PANDITA
  • Publication number: 20230022862
    Abstract: Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile for the active agent indicating treatment efficacy over an extended period of time.
    Type: Application
    Filed: March 1, 2022
    Publication date: January 26, 2023
    Inventors: Parag Shah, Mayank Joshi, Soumen Pattanayek, Divyang Patel, Sandeep Pandita
  • Publication number: 20220296585
    Abstract: Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile for the active agent indicating treatment efficacy over an extended period of time.
    Type: Application
    Filed: June 8, 2022
    Publication date: September 22, 2022
    Inventors: Parag Shah, Mayank Joshi, Soumen Pattanayek, Divyang Patel, Sandeep Pandita
  • Patent number: 11311488
    Abstract: Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile for the active agent indicating treatment efficacy over an extended period of time.
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: April 26, 2022
    Assignee: AUSPEX PHARMACEUTICALS, INC.
    Inventors: Parag Shah, Mayank Joshi, Soumen Pattanayek, Divyang Patel, Sandeep Pandita
  • Publication number: 20210386673
    Abstract: Provided herein are osmotic dosage forms containing deutetrabenazine for use in the treatment of, e.g., hyperkinetic movement disorders. When orally administered to a subject on a once-daily basis, the dosage forms provide a favorable pharmacokinetic profile for the active agent indicating treatment efficacy over an extended period of time.
    Type: Application
    Filed: June 10, 2021
    Publication date: December 16, 2021
    Inventors: Parag Shah, Mayank Joshi, Soumen Pattanayek, Divyang Patel, Sandeep Pandita